Search

AtriCure Inc

Geschlossen

BrancheGesundheitswesen

58.13 -1.21

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

57.67

Max

59.79

Schlüsselkennzahlen

By Trading Economics

Einkommen

8.8M

9M

Verkäufe

12M

154M

KGV

Branchendurchschnitt

265.667

56.432

EPS

0.18

Gewinnspanne

5.83

Angestellte

1,350

EBITDA

-3.8M

3.2M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

-5.34% downside

Dividenden

By Acuity

Nächstes Ergebnis

28. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.1B

2.8B

Vorheriger Eröffnungskurs

59.34

Vorheriger Schlusskurs

58.13

Nachrichtenstimmung

By Acuity

34%

66%

56 / 339 Ranking in Healthcare

AtriCure Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Sept. 2026, 20:02 UTC

AtriCure Inc shares fell sharply, breaking a recent pattern of higher daily closes amid unusually high market volume.

17. Sept. 2026, 20:07 UTC

AtriCure Inc is advancing in today's trading session, continuing a trend that has seen the stock rise significantly since Wednesday's close.

16. Sept. 2026, 19:44 UTC

AtriCure Inc is trading higher, maintaining a price above its 20-day moving average and marking gains in four consecutive sessions.

15. Sept. 2026, 20:07 UTC

News

AtriCure Inc's stock is higher following an insider sale of 5,313 shares by Board Member Regina E. Groves for about $288,070.

14. Sept. 2026, 20:07 UTC

News

AtriCure reports gross revenue of $534.53 million and a net income loss of $11.45 million, with shares advancing amid positive market sentiment.

11. Sept. 2026, 22:11 UTC

AtriCure Inc. shares are lower in after-market trading, continuing a decline since Friday's close amid notably weak overall market conditions.

9. Sept. 2026, 20:07 UTC

AtriCure Inc. shares are lower today, following a notable drop at the open amid broader market volatility. No specific news was identified for the decline.

8. Sept. 2026, 20:01 UTC

News

AtriCure Inc. is trading higher as analysts issue mixed ratings and price targets, with BTIG raising its target to $55.00.

3. Sept. 2026, 20:01 UTC

AtriCure Inc shares are lower during Thursday's session, continuing a decline since Wednesday. No specific news was identified to explain the movement.

2. Sept. 2026, 20:01 UTC

News

AtriCure Inc shares are higher following an upgrade from Needham, raising the price target to $64.00 from $45.00 while maintaining a Buy rating.

1. Sept. 2026, 20:08 UTC

AtriCure Inc. shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains strong above its 20-day moving average.

31. Aug. 2026, 19:26 UTC

AtriCure Inc's shares are lower amid broader market sentiment influenced by interest rate concerns, despite remaining above their 20-day moving average.

28. Aug. 2026, 19:16 UTC

AtriCure Inc shares are lower today, following an early dip. Broader market concerns about inflation and growth expectations may be influencing sentiment.

26. Aug. 2026, 19:08 UTC

News

AtriCure Inc shares are lower amid Health Care Equipment sector weakness and an insider sale of 9,370 shares valued at $458,099.

24. Aug. 2026, 19:36 UTC

News

AtriCure's price target raised to $55 from $45 by BTIG. Shares are higher, reflecting positive sentiment on the company's growth prospects.

20. Aug. 2026, 19:46 UTC

AtriCure Inc shares are higher today, maintaining gains since Wednesday's close, despite earlier fluctuations. The stock remains above its 20-day moving average.

19. Aug. 2026, 20:01 UTC

AtriCure Inc shares are trading higher during Wednesday's session, continuing a strong upward trajectory since Tuesday's close, despite no specific news identified.

18. Aug. 2026, 19:16 UTC

AtriCure Inc shares are higher today, continuing momentum from Monday's close. Broader market factors include rising U.S. Treasury yields amid inflation concerns.

17. Aug. 2026, 22:46 UTC

AtriCure Inc is trading higher in after-market hours, with no specific news identified for the move. The stock remains above its 20-day moving average.

12. Aug. 2026, 20:06 UTC

AtriCure Inc shares are higher today, continuing a nine-session streak of gains. The stock remains above its 20-day moving average.

11. Aug. 2026, 22:41 UTC

AtriCure Inc shares are higher in after-market trading, continuing a recent trend of strength amid changing monetary policies from central banks.

7. Aug. 2026, 20:03 UTC

AtriCure Inc's shares are higher during Friday's session, continuing an upward trend since Thursday's close, and remain above their 20-day moving average.

6. Aug. 2026, 19:12 UTC

AtriCure Inc shares are higher, benefiting from an upward trend in the Health Care Equipment sub-sector. Earlier, the stock peaked before a slight pullback.

5. Aug. 2026, 19:51 UTC

AtriCure Inc shares are higher today, despite no specific news. Broader market sentiment is cautious following ADP's disappointing employment report.

3. Aug. 2026, 20:06 UTC

AtriCure Inc. shares are higher during Monday's session, regaining ground after an earlier pullback. Broader market trends support positive investor sentiment.

31. Juli 2026, 20:03 UTC

News

AtriCure shares are lower amid significant insider selling, including a $233,280 sale by Chief Scientific Officer Vinayak Doraiswamy and options exercised by Board Member Sven Wehrwein.

30. Juli 2026, 18:56 UTC

AtriCure Inc's shares are lower today, impacted by declines in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

29. Juli 2026, 20:03 UTC

News

AtriCure Inc shares reached a 52-week high of $43.18 following better-than-expected quarterly earnings, despite a pullback earlier in the session.

28. Juli 2026, 19:21 UTC

AtriCure Inc's shares are higher today amid stronger gains in U.S. and European indices, with no specific company news identified for the movement.

27. Juli 2026, 20:02 UTC

News

AtriCure Inc shares are higher as the company prepares for two investor conferences and highlights CEO Michael Carrel's leadership appointment.

Peer-Vergleich

Kursveränderung

AtriCure Inc Prognose

Kursziel

By TipRanks

-5.34% Nachteil

12-Monats-Prognose

Durchschnitt 55 USD  -5.34%

Hoch 65 USD

Tief 36 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AtriCure Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

6

Buy

2

Halten

0

Sell

Stimmung

By Acuity

56 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.